Jaguar Health (JAGX) Gross Margin (2015 - 2026)

Jaguar Health (JAGX) has 12 years of Gross Margin data on file, last reported at 94.29% in Q1 2026.

• On a quarterly basis, Gross Margin rose 1755.0% year-over-year to 94.29% in Q1 2026; TTM through Mar 2026 was 85.06%, a 272.0% increase from a year earlier, with the FY2025 full-year figure at 67.21%, down 1606.0% from the prior year.
• Gross Margin for Q1 2026 stood at 94.29%, up from 31.99% in the prior quarter.
• Over the last five years, Gross Margin for JAGX reached as high as 94.29% in Q1 2026 and fell as low as 2175.0% in Q1 2022.
• Historically, Gross Margin has averaged 187.63% across 5 years, with a median of 81.71% in 2024.
• Across the five-year window, Gross Margin sank 222674 bps in 2022 and soared 151701 bps in 2023, its largest moves.
• Year by year, Gross Margin stood at 1446.88% in 2022, then soared by 105 bps to 70.13% in 2023, then rose by 20 bps to 84.13% in 2024, then plunged by 62 bps to 31.99% in 2025, then soared by 195 bps to 94.29% in 2026.
• Per Business Quant data, the three most recent Gross Margin figures were 94.29% in Q1 2026, 31.99% in Q4 2025, and 82.74% in Q3 2025.